Drug
Gdc 7035
Gdc 7035: highest development phase Phase 1, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| GDC-7035 NCT07859085 | Phase 1 | Colorectal Neoplasms |
Latest
No recent events.
Follow Gdc 7035 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.